市場調査レポート

商品コード

1303930

放射性医薬品市場：タイプ別、処置量別、用途別-2023～2030年の世界予測

Radiopharmaceuticals Market by Type, Procedural Volume, Application - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - Global Forecast 2023-2030

出版日: 2023年06月12日 | 発行: 360iResearch

| ページ情報: 英文 195 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　詳細はお問い合わせください。

価格

PDF, Excel & Online Access - 1 Year (Single User License)

USD 4,749 746,257円

レポートPDF及びExcelを1名のみがご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペースト可能です。PDFの印刷は何回でも可能ですが、印刷したもののご利用はPDFのご利用範囲に準拠します。購入後1年間、レポートにオンラインでアクセス可能です。

PDF, Excel & Online Access - 1 Year (Up to 5 User License)

USD 5,749 903,397円

レポートPDF及びExcelを5名まで共有ご利用頂けるライセンスです。ご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペースト可能です。PDFの印刷は何回でも可能ですが、印刷したもののご利用はPDFのご利用範囲に準拠します。購入後1年間、レポートにオンラインでアクセス可能です。

PDF, Excel & Online Access - 1 Year (Site License)

USD 6,749 1,060,537円

レポートPDF及びExcelを同一事業所（所在地）内のすべての方でご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペースト可能です。PDFの印刷は何回でも可能ですが、印刷したもののご利用はPDFのご利用範囲に準拠します。購入後1年間、レポートにオンラインでアクセス可能です。

PDF, Excel & Online Access - 1 Year (Enterprise User License)

USD 8,749 1,374,817円

レポートPDF及びExcelを同一企業の全世界の方にご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペースト可能です。PDFの印刷は何回でも可能ですが、印刷したもののご利用はPDFのご利用範囲に準拠します。購入後1年間、レポートにオンラインでアクセス可能です。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=157.14円

ご注意事項 :

本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

放射性医薬品の世界市場は、2023年に51億5,668万米ドル、CAGR6.45％で大きく成長し、2030年には80億213万米ドルに達すると予測されています。

FPNVポジショニング・マトリックス

FPNVポジショニングマトリックスは世界の放射性医薬品市場を評価するために不可欠です。ビジネス戦略と製品満足度の主要指標を検証することで、ベンダーの包括的な評価を提供し、ユーザーは特定のニーズに基づいた情報をもとに意思決定を行うことができます。この高度な分析により、ベンダーは成功の度合いが異なる4つの象限に整理されます：フォアフロント（F）、パスファインダー（P）、ニッチ（N）、バイタル（V）です。

市場シェア分析

市場シェア分析では、特定の市場領域におけるベンダーの現状を洞察することができます。全体的な収益、顧客基盤、その他の主要指標に対するベンダーの貢献度を比較することで、企業が市場シェアを争う際に、自社の業績や直面している状況をより深く理解することができます。また、本分析では、調査した基準年において、特定のセクターがどの程度競合しているのか、蓄積、断片化の優位性、合併の特徴についても明らかにしています。

本レポートは、以下のポイントに関する洞察を提供します：

1.市場の浸透度：主要企業が提供する市場に関する包括的な情報を提供します。

2.市場の発展：有利な新興市場に関する詳細情報を提供し、市場の成熟セグメントにおける浸透度を分析します。

3.市場の多様化：新製品の上市、未開発地域、最近の開発、投資に関する詳細情報を提供します。

4.市場の動向：COVID-19、ロシア・ウクライナ紛争、高インフレの累積的な影響を包括的に理解することができます。

5.競合の評価と情報：主要企業の市場シェア、戦略、製品、認証、規制状況、特許状況、製造能力を網羅的に評価します。

6.製品開発およびイノベーション：将来技術、研究開発活動、画期的な製品開発に関する知的洞察を提供します。

本レポートは、以下のような質問にお答えします：

1.放射性医薬品の世界市場規模および予測は？

2.予測期間中、世界の放射性医薬品市場を形成するCOVID-19の阻害要因と影響は？

3.放射性医薬品の世界市場において予測期間中に投資すべき製品/セグメント/用途/分野は？

4.放射性医薬品の世界市場における競争戦略は？

5.放射性医薬品の世界市場における技術動向と規制の枠組みは？

6.放射性医薬品の世界市場における主要ベンダーの市場シェアは？

7.放射性医薬品の世界市場への参入には、どのような形態や戦略的な動きが適していると考えられるか？

市場力学
- 促進要因
  - 対象疾患の発生率と有病率の増加
  - アルファ放射線免疫療法に基づく標的がん治療
  - mo-99の需給ギャップ削減に向けた取り組み
- 抑制要因
  - 放射性医薬品の寿命が短い
- 機会
  - 神経学的用途における放射性医薬品の採用
  - 特に新興諸国での診断センターの数が増加
- 課題
  - 高価な機器価格と限られた病院予算
市場動向
COVID-19の累積的な影響
ロシア・ウクライナ紛争の累積的影響
高インフレの累積的影響
ポーターのファイブフォース分析
バリューチェーンとクリティカルパス分析
規制の枠組み
顧客のカスタマイズ

第6章放射性医薬品市場：タイプ別

イントロダクション
診断核医学
- PET放射性医薬品
  - F-18
  - Ru-82
- SPECT放射性医薬品
  - Ga-67
  - I-123
  - TC-99m
  - TL-201
核医学治療
- アルファエミッター
- ベータエミッター
  - I-131
  - Lu-177
  - Re-186
  - SM-153
  - Y-90
- 近接照射療法アイソトープ
  - Cs-131
  - I-125
  - Ir-192
  - Pd-103

第7章放射性医薬品市場：処置量別

イントロダクション
診断
- PET放射性医薬品
- SPECT放射性医薬品
治療
- アルファエミッター
- ベータエミッター
- 近接照射療法アイソトープ

第8章放射性医薬品市場：用途別

イントロダクション
診断用途
- PET用途
  - 心臓病適応症
  - 神経疾患適応症
  - 腫瘍適応症
- SPECT用途
  - 心臓病
  - リンパ腫
  - 神経内科
  - 甲状腺
治療応用
- 骨転移
- 内分泌腫瘍
- リンパ腫治療薬
- 甲状腺治療薬

第9章南北アメリカの放射性医薬品市場

イントロダクション
アルゼンチン
ブラジル
カナダ
メキシコ
米国

第10章アジア太平洋地域の放射性医薬品市場

イントロダクション
オーストラリア
中国
インド
インドネシア
日本
マレーシア
フィリピン
シンガポール
韓国
台湾
タイ
ベトナム

第11章欧州・中東・アフリカの放射性医薬品市場

イントロダクション
デンマーク
エジプト
フィンランド
フランス
ドイツ
イスラエル
イタリア
オランダ
ナイジェリア
ノルウェー
ポーランド
カタール
ロシア
サウジアラビア
南アフリカ
スペイン
スウェーデン
スイス
トルコ
アラブ首長国連邦
英国

第12章競合情勢

FPNVポジショニングマトリクス
市場シェア分析：主要企業別
競合シナリオ分析：主要企業別

第13章掲載企業一覧

第14章付録

ディスカッションガイド
ライセンスと価格について

図表

LIST OF FIGURES

FIGURE 1. RADIOPHARMACEUTICALS MARKET RESEARCH PROCESS
FIGURE 2. RADIOPHARMACEUTICALS MARKET SIZE, 2022 VS 2030
FIGURE 3. RADIOPHARMACEUTICALS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. RADIOPHARMACEUTICALS MARKET SIZE, BY TYPE, 2022 VS 2030 (%)
FIGURE 5. RADIOPHARMACEUTICALS MARKET SIZE, BY PROCEDURAL VOLUME, 2022 VS 2030 (%)
FIGURE 6. RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2022 VS 2030 (%)
FIGURE 7. RADIOPHARMACEUTICALS MARKET SIZE, BY REGION, 2022 VS 2030 (%)
FIGURE 8. RADIOPHARMACEUTICALS MARKET DYNAMICS
FIGURE 9. RADIOPHARMACEUTICALS MARKET SIZE, BY TYPE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 10. RADIOPHARMACEUTICALS MARKET SIZE, BY PROCEDURAL VOLUME, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 11. RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 12. AMERICAS RADIOPHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 13. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 14. ASIA-PACIFIC RADIOPHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 15. EUROPE, MIDDLE EAST & AFRICA RADIOPHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 16. RADIOPHARMACEUTICALS MARKET, FPNV POSITIONING MATRIX, 2022
FIGURE 17. RADIOPHARMACEUTICALS MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

TABLE 1. RADIOPHARMACEUTICALS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
TABLE 3. RADIOPHARMACEUTICALS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. RADIOPHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 5. RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC NUCLEAR MEDICINE, 2018-2030 (USD MILLION)
TABLE 6. RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC NUCLEAR MEDICINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. RADIOPHARMACEUTICALS MARKET SIZE, BY PET RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 8. RADIOPHARMACEUTICALS MARKET SIZE, BY PET RADIOPHARMACEUTICALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. RADIOPHARMACEUTICALS MARKET SIZE, BY F-18, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. RADIOPHARMACEUTICALS MARKET SIZE, BY RU-82, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. RADIOPHARMACEUTICALS MARKET SIZE, BY SPECT RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 12. RADIOPHARMACEUTICALS MARKET SIZE, BY SPECT RADIOPHARMACEUTICALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. RADIOPHARMACEUTICALS MARKET SIZE, BY GA-67, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. RADIOPHARMACEUTICALS MARKET SIZE, BY I-123, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. RADIOPHARMACEUTICALS MARKET SIZE, BY TC-99M, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. RADIOPHARMACEUTICALS MARKET SIZE, BY TL-201, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC NUCLEAR MEDICINE, 2018-2030 (USD MILLION)
TABLE 18. RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC NUCLEAR MEDICINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. RADIOPHARMACEUTICALS MARKET SIZE, BY ALPHA EMITTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. RADIOPHARMACEUTICALS MARKET SIZE, BY BETA EMITTERS, 2018-2030 (USD MILLION)
TABLE 21. RADIOPHARMACEUTICALS MARKET SIZE, BY BETA EMITTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. RADIOPHARMACEUTICALS MARKET SIZE, BY I-131, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. RADIOPHARMACEUTICALS MARKET SIZE, BY LU-177, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. RADIOPHARMACEUTICALS MARKET SIZE, BY RE-186, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. RADIOPHARMACEUTICALS MARKET SIZE, BY SM-153, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. RADIOPHARMACEUTICALS MARKET SIZE, BY Y-90, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. RADIOPHARMACEUTICALS MARKET SIZE, BY BRACHYTHERAPY ISOTOPES, 2018-2030 (USD MILLION)
TABLE 28. RADIOPHARMACEUTICALS MARKET SIZE, BY BRACHYTHERAPY ISOTOPES, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. RADIOPHARMACEUTICALS MARKET SIZE, BY CS-131, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. RADIOPHARMACEUTICALS MARKET SIZE, BY I-125, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. RADIOPHARMACEUTICALS MARKET SIZE, BY IR-192, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. RADIOPHARMACEUTICALS MARKET SIZE, BY PD-103, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. RADIOPHARMACEUTICALS MARKET SIZE, BY PROCEDURAL VOLUME, 2018-2030 (USD MILLION)
TABLE 34. RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC PROCEDURES, 2018-2030 (USD MILLION)
TABLE 35. RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC PROCEDURES, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. RADIOPHARMACEUTICALS MARKET SIZE, BY PET RADIOPHARMACEUTICAL PROCEDURE, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. RADIOPHARMACEUTICALS MARKET SIZE, BY SPECT RADIOPHARMACEUTICALS PROCEDURE, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC PROCEDURES, 2018-2030 (USD MILLION)
TABLE 39. RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC PROCEDURES, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. RADIOPHARMACEUTICALS MARKET SIZE, BY ALPHA EMITTER PROCEDURE, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. RADIOPHARMACEUTICALS MARKET SIZE, BY BETA EMITTERS PROCEDURE, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. RADIOPHARMACEUTICALS MARKET SIZE, BY BRACHYTHERAPY ISOTOPES PROCEDURE, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 44. RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 45. RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC APPLICATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. RADIOPHARMACEUTICALS MARKET SIZE, BY PET APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 47. RADIOPHARMACEUTICALS MARKET SIZE, BY PET APPLICATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. RADIOPHARMACEUTICALS MARKET SIZE, BY CARDIOLOGY INDICATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 49. RADIOPHARMACEUTICALS MARKET SIZE, BY NEUROLOGY INDICATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 50. RADIOPHARMACEUTICALS MARKET SIZE, BY ONCOLOGY INDICATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 51. RADIOPHARMACEUTICALS MARKET SIZE, BY SPECT APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 52. RADIOPHARMACEUTICALS MARKET SIZE, BY SPECT APPLICATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 53. RADIOPHARMACEUTICALS MARKET SIZE, BY CARDIOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 54. RADIOPHARMACEUTICALS MARKET SIZE, BY LYMPHOMA, BY REGION, 2018-2030 (USD MILLION)
TABLE 55. RADIOPHARMACEUTICALS MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 56. RADIOPHARMACEUTICALS MARKET SIZE, BY THYROID, BY REGION, 2018-2030 (USD MILLION)
TABLE 57. RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 58. RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC APPLICATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 59. RADIOPHARMACEUTICALS MARKET SIZE, BY BONE METASTASIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 60. RADIOPHARMACEUTICALS MARKET SIZE, BY ENDOCRINE TUMORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 61. RADIOPHARMACEUTICALS MARKET SIZE, BY LYMPHOMA THERAPEUTIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 62. RADIOPHARMACEUTICALS MARKET SIZE, BY THYROID THERAPEUTIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 63. AMERICAS RADIOPHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 64. AMERICAS RADIOPHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 65. AMERICAS RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC NUCLEAR MEDICINE, 2018-2030 (USD MILLION)
TABLE 66. AMERICAS RADIOPHARMACEUTICALS MARKET SIZE, BY PET RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 67. AMERICAS RADIOPHARMACEUTICALS MARKET SIZE, BY SPECT RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 68. AMERICAS RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC NUCLEAR MEDICINE, 2018-2030 (USD MILLION)
TABLE 69. AMERICAS RADIOPHARMACEUTICALS MARKET SIZE, BY BETA EMITTERS, 2018-2030 (USD MILLION)
TABLE 70. AMERICAS RADIOPHARMACEUTICALS MARKET SIZE, BY BRACHYTHERAPY ISOTOPES, 2018-2030 (USD MILLION)
TABLE 71. AMERICAS RADIOPHARMACEUTICALS MARKET SIZE, BY PROCEDURAL VOLUME, 2018-2030 (USD MILLION)
TABLE 72. AMERICAS RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC PROCEDURES, 2018-2030 (USD MILLION)
TABLE 73. AMERICAS RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC PROCEDURES, 2018-2030 (USD MILLION)
TABLE 74. AMERICAS RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 75. AMERICAS RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 76. AMERICAS RADIOPHARMACEUTICALS MARKET SIZE, BY PET APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 77. AMERICAS RADIOPHARMACEUTICALS MARKET SIZE, BY SPECT APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 78. AMERICAS RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 79. ARGENTINA RADIOPHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 80. ARGENTINA RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC NUCLEAR MEDICINE, 2018-2030 (USD MILLION)
TABLE 81. ARGENTINA RADIOPHARMACEUTICALS MARKET SIZE, BY PET RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 82. ARGENTINA RADIOPHARMACEUTICALS MARKET SIZE, BY SPECT RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 83. ARGENTINA RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC NUCLEAR MEDICINE, 2018-2030 (USD MILLION)
TABLE 84. ARGENTINA RADIOPHARMACEUTICALS MARKET SIZE, BY BETA EMITTERS, 2018-2030 (USD MILLION)
TABLE 85. ARGENTINA RADIOPHARMACEUTICALS MARKET SIZE, BY BRACHYTHERAPY ISOTOPES, 2018-2030 (USD MILLION)
TABLE 86. ARGENTINA RADIOPHARMACEUTICALS MARKET SIZE, BY PROCEDURAL VOLUME, 2018-2030 (USD MILLION)
TABLE 87. ARGENTINA RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC PROCEDURES, 2018-2030 (USD MILLION)
TABLE 88. ARGENTINA RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC PROCEDURES, 2018-2030 (USD MILLION)
TABLE 89. ARGENTINA RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 90. ARGENTINA RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 91. ARGENTINA RADIOPHARMACEUTICALS MARKET SIZE, BY PET APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 92. ARGENTINA RADIOPHARMACEUTICALS MARKET SIZE, BY SPECT APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 93. ARGENTINA RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 94. BRAZIL RADIOPHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 95. BRAZIL RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC NUCLEAR MEDICINE, 2018-2030 (USD MILLION)
TABLE 96. BRAZIL RADIOPHARMACEUTICALS MARKET SIZE, BY PET RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 97. BRAZIL RADIOPHARMACEUTICALS MARKET SIZE, BY SPECT RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 98. BRAZIL RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC NUCLEAR MEDICINE, 2018-2030 (USD MILLION)
TABLE 99. BRAZIL RADIOPHARMACEUTICALS MARKET SIZE, BY BETA EMITTERS, 2018-2030 (USD MILLION)
TABLE 100. BRAZIL RADIOPHARMACEUTICALS MARKET SIZE, BY BRACHYTHERAPY ISOTOPES, 2018-2030 (USD MILLION)
TABLE 101. BRAZIL RADIOPHARMACEUTICALS MARKET SIZE, BY PROCEDURAL VOLUME, 2018-2030 (USD MILLION)
TABLE 102. BRAZIL RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC PROCEDURES, 2018-2030 (USD MILLION)
TABLE 103. BRAZIL RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC PROCEDURES, 2018-2030 (USD MILLION)
TABLE 104. BRAZIL RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 105. BRAZIL RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 106. BRAZIL RADIOPHARMACEUTICALS MARKET SIZE, BY PET APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 107. BRAZIL RADIOPHARMACEUTICALS MARKET SIZE, BY SPECT APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 108. BRAZIL RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 109. CANADA RADIOPHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 110. CANADA RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC NUCLEAR MEDICINE, 2018-2030 (USD MILLION)
TABLE 111. CANADA RADIOPHARMACEUTICALS MARKET SIZE, BY PET RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 112. CANADA RADIOPHARMACEUTICALS MARKET SIZE, BY SPECT RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 113. CANADA RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC NUCLEAR MEDICINE, 2018-2030 (USD MILLION)
TABLE 114. CANADA RADIOPHARMACEUTICALS MARKET SIZE, BY BETA EMITTERS, 2018-2030 (USD MILLION)
TABLE 115. CANADA RADIOPHARMACEUTICALS MARKET SIZE, BY BRACHYTHERAPY ISOTOPES, 2018-2030 (USD MILLION)
TABLE 116. CANADA RADIOPHARMACEUTICALS MARKET SIZE, BY PROCEDURAL VOLUME, 2018-2030 (USD MILLION)
TABLE 117. CANADA RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC PROCEDURES, 2018-2030 (USD MILLION)
TABLE 118. CANADA RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC PROCEDURES, 2018-2030 (USD MILLION)
TABLE 119. CANADA RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 120. CANADA RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 121. CANADA RADIOPHARMACEUTICALS MARKET SIZE, BY PET APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 122. CANADA RADIOPHARMACEUTICALS MARKET SIZE, BY SPECT APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 123. CANADA RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 124. MEXICO RADIOPHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 125. MEXICO RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC NUCLEAR MEDICINE, 2018-2030 (USD MILLION)
TABLE 126. MEXICO RADIOPHARMACEUTICALS MARKET SIZE, BY PET RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 127. MEXICO RADIOPHARMACEUTICALS MARKET SIZE, BY SPECT RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 128. MEXICO RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC NUCLEAR MEDICINE, 2018-2030 (USD MILLION)
TABLE 129. MEXICO RADIOPHARMACEUTICALS MARKET SIZE, BY BETA EMITTERS, 2018-2030 (USD MILLION)
TABLE 130. MEXICO RADIOPHARMACEUTICALS MARKET SIZE, BY BRACHYTHERAPY ISOTOPES, 2018-2030 (USD MILLION)
TABLE 131. MEXICO RADIOPHARMACEUTICALS MARKET SIZE, BY PROCEDURAL VOLUME, 2018-2030 (USD MILLION)
TABLE 132. MEXICO RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC PROCEDURES, 2018-2030 (USD MILLION)
TABLE 133. MEXICO RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC PROCEDURES, 2018-2030 (USD MILLION)
TABLE 134. MEXICO RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 135. MEXICO RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 136. MEXICO RADIOPHARMACEUTICALS MARKET SIZE, BY PET APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 137. MEXICO RADIOPHARMACEUTICALS MARKET SIZE, BY SPECT APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 138. MEXICO RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 139. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 140. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 141. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC NUCLEAR MEDICINE, 2018-2030 (USD MILLION)
TABLE 142. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY PET RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 143. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY SPECT RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 144. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC NUCLEAR MEDICINE, 2018-2030 (USD MILLION)
TABLE 145. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY BETA EMITTERS, 2018-2030 (USD MILLION)
TABLE 146. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY BRACHYTHERAPY ISOTOPES, 2018-2030 (USD MILLION)
TABLE 147. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY PROCEDURAL VOLUME, 2018-2030 (USD MILLION)
TABLE 148. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC PROCEDURES, 2018-2030 (USD MILLION)
TABLE 149. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC PROCEDURES, 2018-2030 (USD MILLION)
TABLE 150. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 151. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 152. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY PET APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 153. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY SPECT APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 154. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 155. ASIA-PACIFIC RADIOPHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 156. ASIA-PACIFIC RADIOPHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 157. ASIA-PACIFIC RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC NUCLEAR MEDICINE, 2018-2030 (USD MILLION)
TABLE 158. ASIA-PACIFIC RADIOPHARMACEUTICALS MARKET SIZE, BY PET RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 159. ASIA-PACIFIC RADIOPHARMACEUTICALS MARKET SIZE, BY SPECT RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 160. ASIA-PACIFIC RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC NUCLEAR MEDICINE, 2018-2030 (USD MILLION)
TABLE 161. ASIA-PACIFIC RADIOPHARMACEUTICALS MARKET SIZE, BY BETA EMITTERS, 2018-2030 (USD MILLION)
TABLE 162. ASIA-PACIFIC RADIOPHARMACEUTICALS MARKET SIZE, BY BRACHYTHERAPY ISOTOPES, 2018-2030 (USD MILLION)
TABLE 163. ASIA-PACIFIC RADIOPHARMACEUTICALS MARKET SIZE, BY PROCEDURAL VOLUME, 2018-2030 (USD MILLION)
TABLE 164. ASIA-PACIFIC RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC PROCEDURES, 2018-2030 (USD MILLION)
TABLE 165. ASIA-PACIFIC RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC PROCEDURES, 2018-2030 (USD MILLION)
TABLE 166. ASIA-PACIFIC RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 167. ASIA-PACIFIC RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 168. ASIA-PACIFIC RADIOPHARMACEUTICALS MARKET SIZE, BY PET APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 169. ASIA-PACIFIC RADIOPHARMACEUTICALS MARKET SIZE, BY SPECT APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 170. ASIA-PACIFIC RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 171. AUSTRALIA RADIOPHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 172. AUSTRALIA RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC NUCLEAR MEDICINE, 2018-2030 (USD MILLION)
TABLE 173. AUSTRALIA RADIOPHARMACEUTICALS MARKET SIZE, BY PET RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 174. AUSTRALIA RADIOPHARMACEUTICALS MARKET SIZE, BY SPECT RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 175. AUSTRALIA RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC NUCLEAR MEDICINE, 2018-2030 (USD MILLION)
TABLE 176. AUSTRALIA RADIOPHARMACEUTICALS MARKET SIZE, BY BETA EMITTERS, 2018-2030 (USD MILLION)
TABLE 177. AUSTRALIA RADIOPHARMACEUTICALS MARKET SIZE, BY BRACHYTHERAPY ISOTOPES, 2018-2030 (USD MILLION)
TABLE 178. AUSTRALIA RADIOPHARMACEUTICALS MARKET SIZE, BY PROCEDURAL VOLUME, 2018-2030 (USD MILLION)
TABLE 179. AUSTRALIA RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC PROCEDURES, 2018-2030 (USD MILLION)
TABLE 180. AUSTRALIA RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC PROCEDURES, 2018-2030 (USD MILLION)
TABLE 181. AUSTRALIA RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 182. AUSTRALIA RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 183. AUSTRALIA RADIOPHARMACEUTICALS MARKET SIZE, BY PET APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 184. AUSTRALIA RADIOPHARMACEUTICALS MARKET SIZE, BY SPECT APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 185. AUSTRALIA RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 186. CHINA RADIOPHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 187. CHINA RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC NUCLEAR MEDICINE, 2018-2030 (USD MILLION)
TABLE 188. CHINA RADIOPHARMACEUTICALS MARKET SIZE, BY PET RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 189. CHINA RADIOPHARMACEUTICALS MARKET SIZE, BY SPECT RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 190. CHINA RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC NUCLEAR MEDICINE, 2018-2030 (USD MILLION)
TABLE 191. CHINA RADIOPHARMACEUTICALS MARKET SIZE, BY BETA EMITTERS, 2018-2030 (USD MILLION)
TABLE 192. CHINA RADIOPHARMACEUTICALS MARKET SIZE, BY BRACHYTHERAPY ISOTOPES, 2018-2030 (USD MILLION)
TABLE 193. CHINA RADIOPHARMACEUTICALS MARKET SIZE, BY PROCEDURAL VOLUME, 2018-2030 (USD MILLION)
TABLE 194. CHINA RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC PROCEDURES, 2018-2030 (USD MILLION)
TABLE 195. CHINA RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC PROCEDURES, 2018-2030 (USD MILLION)
TABLE 196. CHINA RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 197. CHINA RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 198. CHINA RADIOPHARMACEUTICALS MARKET SIZE, BY PET APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 199. CHINA RADIOPHARMACEUTICALS MARKET SIZE, BY SPECT APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 200. CHINA RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 201. INDIA RADIOPHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 202. INDIA RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC NUCLEAR MEDICINE, 2018-2030 (USD MILLION)
TABLE 203. INDIA RADIOPHARMACEUTICALS MARKET SIZE, BY PET RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 204. INDIA RADIOPHARMACEUTICALS MARKET SIZE, BY SPECT RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 205. INDIA RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC NUCLEAR MEDICINE, 2018-2030 (USD MILLION)
TABLE 206. INDIA RADIOPHARMACEUTICALS MARKET SIZE, BY BETA EMITTERS, 2018-2030 (USD MILLION)
TABLE 207. INDIA RADIOPHARMACEUTICALS MARKET SIZE, BY BRACHYTHERAPY ISOTOPES, 2018-2030 (USD MILLION)
TABLE 208. INDIA RADIOPHARMACEUTICALS MARKET SIZE, BY PROCEDURAL VOLUME, 2018-2030 (USD MILLION)
TABLE 209. INDIA RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC PROCEDURES, 2018-2030 (USD MILLION)
TABLE 210. INDIA RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC PROCEDURES, 2018-2030 (USD MILLION)
TABLE 211. INDIA RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 212. INDIA RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 213. INDIA RADIOPHARMACEUTICALS MARKET SIZE, BY PET APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 214. INDIA RADIOPHARMACEUTICALS MARKET SIZE, BY SPECT APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 215. INDIA RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 216. INDONESIA RADIOPHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 217. INDONESIA RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC NUCLEAR MEDICINE, 2018-2030 (USD MILLION)
TABLE 218. INDONESIA RADIOPHARMACEUTICALS MARKET SIZE, BY PET RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 219. INDONESIA RADIOPHARMACEUTICALS MARKET SIZE, BY SPECT RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 220. INDONESIA RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC NUCLEAR MEDICINE, 2018-2030 (USD MILLION)
TABLE 221. INDONESIA RADIOPHARMACEUTICALS MARKET SIZE, BY BETA EMITTERS, 2018-2030 (USD MILLION)
TABLE 222. INDONESIA RADIOPHARMACEUTICALS MARKET SIZE, BY BRACHYTHERAPY ISOTOPES, 2018-2030 (USD MILLION)
TABLE 223. INDONESIA RADIOPHARMACEUTICALS MARKET SIZE, BY PROCEDURAL VOLUME, 2018-2030 (USD MILLION)
TABLE 224. INDONESIA RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC PROCEDURES, 2018-2030 (USD MILLION)
TABLE 225. INDONESIA RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC PROCEDURES, 2018-2030 (USD MILLION)
TABLE 226. INDONESIA RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 227. INDONESIA RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 228. INDONESIA RADIOPHARMACEUTICALS MARKET SIZE, BY PET APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 229. INDONESIA RADIOPHARMACEUTICALS MARKET SIZE, BY SPECT APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 230. INDONESIA RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 231. JAPAN RADIOPHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 232. JAPAN RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC NUCLEAR MEDICINE, 2018-2030 (USD MILLION)
TABLE 233. JAPAN RADIOPHARMACEUTICALS MARKET SIZE, BY PET RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 234. JAPAN RADIOPHARMACEUTICALS MARKET SIZE, BY SPECT RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 235. JAPAN RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC NUCLEAR MEDICINE, 2018-2030 (USD MILLION)
TABLE 236. JAPAN RADIOPHARMACEUTICALS MARKET SIZE, BY BETA EMITTERS, 2018-2030 (USD MILLION)
TABLE 237. JAPAN RADIOPHARMACEUTICALS MARKET SIZE, BY BRACHYTHERAPY ISOTOPES, 2018-2030 (USD MILLION)
TABLE 238. JAPAN RADIOPHARMACEUTICALS MARKET SIZE, BY PROCEDURAL VOLUME, 2018-2030 (USD MILLION)
TABLE 239. JAPAN RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC PROCEDURES, 2018-2030 (USD MILLION)
TABLE 240. JAPAN RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC PROCEDURES, 2018-2030 (USD MILLION)
TABLE 241. JAPAN RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 242. JAPAN RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 243. JAPAN RADIOPHARMACEUTICALS MARKET SIZE, BY PET APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 244. JAPAN RADIOPHARMACEUTICALS MARKET SIZE, BY SPECT APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 245. JAPAN RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 246. MALAYSIA RADIOPHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 247. MALAYSIA RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC NUCLEAR MEDICINE, 2018-2030 (USD MILLION)
TABLE 248. MALAYSIA RADIOPHARMACEUTICALS MARKET SIZE, BY PET RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 249. MALAYSIA RADIOPHARMACEUTICALS MARKET SIZE, BY SPECT RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 250. MALAYSIA RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC NUCLEAR MEDICINE, 2018-2030 (USD MILLION)
TABLE 251. MALAYSIA RADIOPHARMACEUTICALS MARKET SIZE, BY BETA EMITTERS, 2018-2030 (USD MILLION)
TABLE 252. MALAYSIA RADIOPHARMACEUTICALS MARKET SIZE, BY BRACHYTHERAPY ISOTOPES, 2018-2030 (USD MILLION)
TABLE 253. MALAYSIA RADIOPHARMACEUTICALS MARKET SIZE, BY PROCEDURAL VOLUME, 2018-2030 (USD MILLION)
TABLE 254. MALAYSIA RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC PROCEDURES, 2018-2030 (USD MILLION)
TABLE 255. MALAYSIA RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC PROCEDURES, 2018-2030 (USD MILLION)
TABLE 256. MALAYSIA RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 257. MALAYSIA RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 258. MALAYSIA RADIOPHARMACEUTICALS MARKET SIZE, BY PET APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 259. MALAYSIA RADIOPHARMACEUTICALS MARKET SIZE, BY SPECT APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 260. MALAYSIA RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 261. PHILIPPINES RADIOPHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 262. PHILIPPINES RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC NUCLEAR MEDICINE, 2018-2030 (USD MILLION)
TABLE 263. PHILIPPINES RADIOPHARMACEUTICALS MARKET SIZE, BY PET RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 264. PHILIPPINES RADIOPHARMACEUTICALS MARKET SIZE, BY SPECT RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 265. PHILIPPINES RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC NUCLEAR MEDICINE, 2018-2030 (USD MILLION)
TABLE 266. PHILIPPINES RADIOPHARMACEUTICALS MARKET SIZE, BY BETA EMITTERS, 2018-2030 (USD MILLION)
TABLE 267. PHILIPPINES RADIOPHARMACEUTICALS MARKET SIZE, BY BRACHYTHERAPY ISOTOPES, 2018-2030 (USD MILLION)
TABLE 268. PHILIPPINES RADIOPHARMACEUTICALS MARKET SIZE, BY PROCEDURAL VOLUME, 2018-2030 (USD MILLION)
TABLE 269. PHILIPPINES RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC PROCEDURES, 2018-2030 (USD MILLION)
TABLE 270. PHILIPPINES RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC PROCEDURES, 2018-2030 (USD MILLION)
TABLE 271. PHILIPPINES RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 272. PHILIPPINES RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 273. PHILIPPINES RADIOPHARMACEUTICALS MARKET SIZE, BY PET APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 274. PHILIPPINES RADIOPHARMACEUTICALS MARKET SIZE, BY SPECT APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 275. PHILIPPINES RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 276. SINGAPORE RADIOPHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 277. SINGAPORE RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC NUCLEAR MEDICINE, 2018-2030 (USD MILLION)
TABLE 278. SINGAPORE RADIOPHARMACEUTICALS MARKET SIZE, BY PET RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 279. SINGAPORE RADIOPHARMACEUTICALS MARKET SIZE, BY SPECT RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 280. SINGAPORE RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC NUCLEAR MEDICINE, 2018-2030 (USD MILLION)
TABLE 281. SINGAPORE RADIOPHARMACEUTICALS MARKET SIZE, BY BETA EMITTERS, 2018-2030 (USD MILLION)
TABLE 282. SINGAPORE RADIOPHARMACEUTICALS MARKET SIZE, BY BRACHYTHERAPY ISOTOPES, 2018-2030 (USD MILLION)
TABLE 283. SINGAPORE RADIOPHARMACEUTICALS MARKET SIZE, BY PROCEDURAL VOLUME, 2018-2030 (USD MILLION)
TABLE 284. SINGAPORE RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC PROCEDURES, 2018-2030 (USD MILLION)
TABLE 285. SINGAPORE RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC PROCEDURES, 2018-2030 (USD MILLION)
TABLE 286. SINGAPORE RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 287. SINGAPORE RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 288. SINGAPORE RADIOPHARMACEUTICALS MARKET SIZE, BY PET APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 289. SINGAPORE RADIOPHARMACEUTICALS MARKET SIZE, BY SPECT APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 290. SINGAPORE RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 291. SOUTH KOREA RADIOPHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 292. SOUTH KOREA RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC NUCLEAR MEDICINE, 2018-2030 (USD MILLION)
TABLE 293. SOUTH KOREA RADIOPHARMACEUTICALS MARKET SIZE, BY PET RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 294. SOUTH KOREA RADIOPHARMACEUTICALS MARKET SIZE, BY SPECT RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 295. SOUTH KOREA RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC NUCLEAR MEDICINE, 2018-2030 (USD MILLION)
TABLE 296. SOUTH KOREA RADIOPHARMACEUTICALS MARKET SIZE, BY BETA EMITTERS, 2018-2030 (USD MILLION)
TABLE 297. SOUTH KOREA RADIOPHARMACEUTICALS MARKET SIZE, BY BRACHYTHERAPY ISOTOPES, 2018-2030 (USD MILLION)
TABLE 298. SOUTH KOREA RADIOPHARMACEUTICALS MARKET SIZE, BY PROCEDURAL VOLUME, 2018-2030 (USD MILLION)
TABLE 299. SOUTH KOREA RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC PROCEDURES, 2018-2030 (USD MILLION)
TABLE 300. SOUTH KOREA RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC PROCEDURES, 2018-2030 (USD MILLION)
TABLE 301. SOUTH KOREA RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 302. SOUTH KOREA RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 303. SOUTH KOREA RADIOPHARMACEUTICALS MARKET SIZE, BY PET APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 304. SOUTH KOREA RADIOPHARMACEUTICALS MARKET SIZE, BY SPECT APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 305. SOUTH KOREA RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 306. TAIWAN RADIOPHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 307. TAIWAN RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC NUCLEAR MEDICINE, 2018-2030 (USD MILLION)
TABLE 308. TAIWAN RADIOPHARMACEUTICALS MARKET SIZE, BY PET RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 309. TAIWAN RADIOPHARMACEUTICALS MARKET SIZE, BY SPECT RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 310. TAIWAN RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC NUCLEAR MEDICINE, 2018-2030 (USD MILLION)
TABLE 311. TAIWAN RADIOPHARMACEUTICALS MARKET SIZE, BY BETA EMITTERS, 2018-2030 (USD MILLION)
TABLE 312. TAIWAN RADIOPHARMACEUTICALS MARKET SIZE, BY BRACHYTHERAPY ISOTOPES, 2018-2030 (USD MILLION)
TABLE 313. TAIWAN RADIOPHARMACEUTICALS MARKET SIZE, BY PROCEDURAL VOLUME, 2018-2030 (USD MILLION)
TABLE 314. TAIWAN RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC PROCEDURES, 2018-2030 (USD MILLION)
TABLE 315. TAIWAN RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC PROCEDURES, 2018-2030 (USD MILLION)
TABLE 316. TAIWAN RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 317. TAIWAN RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 318. TAIWAN RADIOPHARMACEUTICALS MARKET SIZE, BY PET APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 319. TAIWAN RADIOPHARMACEUTICALS MARKET SIZE, BY SPECT APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 320. TAIWAN RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 321. THAILAND RADIOPHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 322. THAILAND RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC NUCLEAR MEDICINE, 2018-2030 (USD MILLION)
TABLE 323. THAILAND RADIOPHARMACEUTICALS MARKET SIZE, BY PET RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 324. THAILAND RADIOPHARMACEUTICALS MARKET SIZE, BY SPE

Product Code: MRR-4308E1C887AD

The Global Radiopharmaceuticals Market is forecasted to grow significantly, with a projected USD 5,156.68 million in 2023 at a CAGR of 6.45% and expected to reach a staggering USD 8,002.13 million by 2030.

The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global Radiopharmaceuticals Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global Radiopharmaceuticals Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Type, market is studied across Diagnostic Nuclear Medicine and Therapeutic Nuclear Medicine. The Diagnostic Nuclear Medicine is further studied across Pet Radiopharmaceuticals and Spect Radiopharmaceuticals. The Pet Radiopharmaceuticals is further studied across F-18 and Ru-82. The Spect Radiopharmaceuticals is further studied across Ga-67, I-123, Tc-99m, and Tl-201. The Therapeutic Nuclear Medicine is further studied across Alpha Emitters, Beta Emitters, and Brachytherapy Isotopes. The Beta Emitters is further studied across I-131, Lu-177, Re-186, Sm-153, and Y-90. The Brachytherapy Isotopes is further studied across Cs-131, I-125, Ir-192, and Pd-103. The Therapeutic Nuclear Medicine commanded largest market share of 59.95% in 2022, followed by Diagnostic Nuclear Medicine.

Based on Procedural Volume, market is studied across Diagnostic Procedures and Therapeutic Procedures. The Diagnostic Procedures is further studied across Pet Radiopharmaceutical Procedure and Spect Radiopharmaceuticals Procedure. The Therapeutic Procedures is further studied across Alpha Emitter Procedure, Beta Emitters Procedure, and Brachytherapy Isotopes Procedure. The Therapeutic Procedures commanded largest market share of 62.54% in 2022, followed by Diagnostic Procedures.

Based on Application, market is studied across Diagnostic Applications and Therapeutic Applications. The Diagnostic Applications is further studied across Pet Applications and Spect Applications. The Pet Applications is further studied across Cardiology Indication, Neurology Indication, and Oncology Indication. The Spect Applications is further studied across Cardiology, Lymphoma, Neurology, and Thyroid. The Therapeutic Applications is further studied across Bone Metastasis, Endocrine Tumors, Lymphoma Therapeutic, and Thyroid Therapeutic. The Therapeutic Applications commanded largest market share of 58.18% in 2022, followed by Diagnostic Applications.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Europe, Middle East & Africa commanded largest market share of 35.14% in 2022, followed by Americas.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global Radiopharmaceuticals Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Radiopharmaceuticals Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Radiopharmaceuticals Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Radiopharmaceuticals Market?

4. What is the competitive strategic window for opportunities in the Global Radiopharmaceuticals Market?

5. What are the technology trends and regulatory frameworks in the Global Radiopharmaceuticals Market?

6. What is the market share of the leading vendors in the Global Radiopharmaceuticals Market?

7. What modes and strategic moves are considered suitable for entering the Global Radiopharmaceuticals Market?

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

4.1. Introduction
4.2. Radiopharmaceuticals Market, by Type, 2022 vs 2030
4.3. Radiopharmaceuticals Market, by Procedural Volume, 2022 vs 2030
4.4. Radiopharmaceuticals Market, by Application, 2022 vs 2030
4.5. Radiopharmaceuticals Market, by Region, 2022 vs 2030

5. Market Insights

5.1. Market Dynamics
- 5.1.1. Drivers
  - 5.1.1.1. Increasing Incidence and Prevalence of Target Conditions
  - 5.1.1.2. Alpha Radioimmunotherapy-Based Targeted Cancer Treatment
  - 5.1.1.3. Initiatives To Reduce The Demand-Supply Gap of mo-99
- 5.1.2. Restraints
  - 5.1.2.1. Shorter Life of Radiopharmaceuticals
- 5.1.3. Opportunities
  - 5.1.3.1. Adoption of Radiopharmaceuticals in Neurological Applications
  - 5.1.3.2. Rising Number of Diagnostic Centers Especially in Developing Countries
- 5.1.4. Challenges
  - 5.1.4.1. High Equipment Prices and Limited Hospital Budget
5.2. Market Trends
5.3. Cumulative Impact of COVID-19
5.4. Cumulative Impact of Russia-Ukraine Conflict
5.5. Cumulative Impact of High Inflation
5.6. Porter's Five Forces Analysis
- 5.6.1. Threat of New Entrants
- 5.6.2. Threat of Substitutes
- 5.6.3. Bargaining Power of Customers
- 5.6.4. Bargaining Power of Suppliers
- 5.6.5. Industry Rivalry
5.7. Value Chain & Critical Path Analysis
5.8. Regulatory Framework
5.9. Client Customization

6. Radiopharmaceuticals Market, by Type

6.1. Introduction
6.2. Diagnostic Nuclear Medicine
- 6.2.1. Pet Radiopharmaceuticals
  - 6.2.1.1. F-18
  - 6.2.1.2. Ru-82
- 6.2.2. Spect Radiopharmaceuticals
  - 6.2.2.1. Ga-67
  - 6.2.2.2. I-123
  - 6.2.2.3. Tc-99m
  - 6.2.2.4. Tl-201
6.3. Therapeutic Nuclear Medicine
- 6.3.1. Alpha Emitters
- 6.3.2. Beta Emitters
  - 6.3.2.1. I-131
  - 6.3.2.2. Lu-177
  - 6.3.2.3. Re-186
  - 6.3.2.4. Sm-153
  - 6.3.2.5. Y-90
- 6.3.3. Brachytherapy Isotopes
  - 6.3.3.1. Cs-131
  - 6.3.3.2. I-125
  - 6.3.3.3. Ir-192
  - 6.3.3.4. Pd-103

7. Radiopharmaceuticals Market, by Procedural Volume

7.1. Introduction
7.2. Diagnostic Procedures
- 7.2.1. Pet Radiopharmaceutical Procedure
- 7.2.2. Spect Radiopharmaceuticals Procedure
7.3. Therapeutic Procedures
- 7.3.1. Alpha Emitter Procedure
- 7.3.2. Beta Emitters Procedure
- 7.3.3. Brachytherapy Isotopes Procedure

8. Radiopharmaceuticals Market, by Application

8.1. Introduction
8.2. Diagnostic Applications
- 8.2.1. Pet Applications
  - 8.2.1.1. Cardiology Indication
  - 8.2.1.2. Neurology Indication
  - 8.2.1.3. Oncology Indication
- 8.2.2. Spect Applications
  - 8.2.2.1. Cardiology
  - 8.2.2.2. Lymphoma
  - 8.2.2.3. Neurology
  - 8.2.2.4. Thyroid
8.3. Therapeutic Applications
- 8.3.1. Bone Metastasis
- 8.3.2. Endocrine Tumors
- 8.3.3. Lymphoma Therapeutic
- 8.3.4. Thyroid Therapeutic

9. Americas Radiopharmaceuticals Market

9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States

10. Asia-Pacific Radiopharmaceuticals Market

10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam

11. Europe, Middle East & Africa Radiopharmaceuticals Market

11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom

放射性医薬品市場：タイプ別、処置量別、用途別-2023～2030年の世界予測

Radiopharmaceuticals Market by Type, Procedural Volume, Application - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - Global Forecast 2023-2030

FPNVポジショニング・マトリックス

市場シェア分析

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

第6章 放射性医薬品市場：タイプ別

第7章 放射性医薬品市場：処置量別

第8章 放射性医薬品市場：用途別

第9章 南北アメリカの放射性医薬品市場

第10章 アジア太平洋地域の放射性医薬品市場

第11章 欧州・中東・アフリカの放射性医薬品市場

第12章 競合情勢

第13章 掲載企業一覧

第14章 付録